FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Michel Scherrmann

Research Profile

Physiology

Chemicals & Drugs

Living Beings

Anatomy

Brain

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
salvatore cisternino; Marcel Debray; Pascal André; Hélène Chapy; Maria Smirnova; Jean-Michel Scherrmann
Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
Sumio Ohtsuki; Yumi Sakamoto; Jean-Michel Scherrmann; Masanori Tachikawa; Pierre-Olivier Couraud; Xavier Decleves; Fabienne Glacial; Chiemi Ikeda; Yoshiyuki Kubo; Florence Miller; Yasuo Uchida; Tetsuya Terasaki
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ramzi Shawahna; Xavier Decleves; Jean-Michel Scherrmann
Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Michel Scherrmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: salvatore cisternino; Marcel Debray; Pascal André; Hélène Chapy; Maria Smirnova; Jean-Michel Scherrmann
Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
The AAPS journal 2013;15(2):299-307.
2013: Sumio Ohtsuki; Yumi Sakamoto; Jean-Michel Scherrmann; Masanori Tachikawa; Pierre-Olivier Couraud; Xavier Decleves; Fabienne Glacial; Chiemi Ikeda; Yoshiyuki Kubo; Florence Miller; Yasuo Uchida; Tetsuya Terasaki
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Molecular pharmaceutics 2013;10(1):289-96.
2013: Ramzi Shawahna; Xavier Decleves; Jean-Michel Scherrmann
Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Current drug metabolism 2013;14(1):120-36.
2012: Hisham Alhaddad; Frédéric J Baud; Capucine Besengez; Fouad Chiadmi; salvatore cisternino; Xavier Declèves; Patricia Risède; Jean-Michel Scherrmann; Joël Schlatter; Maria Smirnova; Nicolas Tournier; Bruno Mégarbane
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.
Critical care medicine 2012;40(12):3215-23.
2012: Kathryn Ball; François Bouzom; Jean-Michel Scherrmann; Bernard Walther; Xavier Declèves
Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone.
Journal of pharmaceutical sciences 2012;101(11):4277-92.
2012: Pascal André; Julie Cattelotte; Véronique Cochois-Guégan; Cynthia Marie-Claire; Bruno Saubaméa; Jean-Michel Scherrmann; Alfred H Schinkel; Maria Smirnova; salvatore cisternino
Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012;32(11):1989-2001.
2012: salah yousif; Catarina Chaves; Isabelle Margaill; Sophie Potin; Jean-Michel Scherrmann; Xavier Declèves
Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
Journal of neurochemistry 2012;123(4):491-503.
2012: Nicolas Tournier; Michel Bottlaender; Salvatore Cisternino; Frederic Dolle; Sébastien Goutal; Marie-Anne Peyronneau; Wadad Saba; Jean-Michel Scherrmann; Héric Valette
Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.
Pharmaceutical research 2012;29(9):2468-76.
2012: Sandra Manceau; Jean-Yves Perrot; Jean-Michel Scherrmann; Frédéric Batteux; Christiane Chéreau; Sandrine Chouzenoux; Xavier Declèves; Carole Giraud; Bernard Weill; Jean-Marc Tréluyer
Expression and induction by dexamethasone of ABC transporters and nuclear receptors in a human T-lymphocyte cell line.
Journal of chemotherapy (Florence, Italy) 2012;24(1):48-55.
2012: Aude Jacob; Xavier Declèves; Jean-Michel Scherrmann
[Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
Biologie aujourd'hui 2012;206(3):177-83.
2012: Tuan Minh Do; Robert Farinotti; Marie-Sophie Noel-Hudson; Sandy Ribes; Jean-Michel Scherrmann; Maria Smirnova; Marion Buyse; Frederic Calon; Hélène Chacun; Giovanna Chimini; salvatore cisternino; Capucine Besengez; Fanchon Bourasset
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Journal of Alzheimer's disease : JAD 2012;30(1):155-66.
2011: Ramzi Shawahna; Tetsuya Terasaki; Yasuo Uchida; salah yousif; Francine Chassoux; Pierre-Olivier Couraud; Sandrine Dauchy; Catherine Daumas-Duport; Xavier Declèves; Aude Jacob; Sumio Ohtsuki; Jean-Michel Scherrmann
Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.
Molecular pharmaceutics 2011;8(4):1332-41.
2011: Aline Hajj; Kamilia Ksouda; Jacques Callebert; Xavier Declèves; Jean-Pierre Lepine; Katell Peoc'h; Lydia Rabbaa-Khabbaz; Jean-Michel Scherrmann; Florence Vorspan; Jean-Louis Laplanche
How to obtain DNA from injection drug users?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2011;49(8):1391-2.
2011: Nicolas Tournier; Héric Valette; Marie-Anne Peyronneau; Wadad Saba; Sébastien Goutal; Bertrand Kuhnast; Frédéric Dollé; Jean-Michel Scherrmann; Salvatore Cisternino; Michel Bottlaender
Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(3):415-23.
2011: Aude Jacob; Sophie Potin; Jean-Michel Scherrmann; salah yousif; Björn Bauer; Xavier COUMOUL; Anika Ms Hartz; Xavier Declèves
Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels.
Fluids and barriers of the CNS 2011;8():23.
2011: Nicolas Tournier; Xavier Declèves; Bruno Saubaméa; Jean-Michel Scherrmann; salvatore cisternino
Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
Current pharmaceutical design 2011;17(26):2829-42.
2010: Marie-Claude Menet; Julien Fonsart; Françoise Hervé; Dominique Fompeydie; Martine Galliot-Guilley; Florence Noble; Jean-Michel Scherrmann
Determination of 3,4-methylenedioxymethamphetamine and its five main metabolites in rat urine by solid-phase extraction and high performance liquid chromatography with on line mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(28):2905-10.
2010: Arnaud Bruyère; Xavier Declèves; Catie Marques; Yves Panis; Marc Pocard; Jean-Michel Scherrmann; Xavier Treton; Patrice Valleur; Kathryn Ball; Yoram Bouhnik; Francois Bouzom; Stéphane Mouly
Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
Molecular pharmaceutics 2010;7(5):1596-607.
2010: Fabien Dutheil; Aude Jacob; Sandrine Dauchy; Philippe Beaune; Jean-Michel Scherrmann; Xavier Declèves; Marie-Anne Loriot
ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.
Expert opinion on drug metabolism & toxicology 2010;6(10):1161-74.
2010: Florence Vorspan; Kamilia Ksouda; Vanessa Bloch; Jean-Louis Laplanche; Katell Peoc'h; Aline Hajj; Jean-Michel Scherrmann; Stéphane Mouly; Jean-Pierre Lépine
A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(5):458-9.
2010: Sihem Ait-Oudhia; Jean-Michel Scherrmann; Wojciech Krzyzanski
Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
The Journal of pharmacology and experimental therapeutics 2010;334(3):897-910.
2010: S Manceau; C Giraud; Xavier Declèves; F Batteux; Sandrine Chouzenoux; R Tang; S Dauchy; Jean-Michel Scherrmann; Bernard Weill; J P Morini; J Y Perrot; J M Tréluyer
Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes.
International journal of pharmaceutics 2010;395(1-2):98-103.
2010: Nicolas Tournier; Lucie Chevillard; Bruno Megarbane; Stephane Pirnay; Jean-Michel Scherrmann; Xavier Declèves
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(7):905-15.
2010: Sihem Ait-Oudhia; Jean-Michel Scherrmann; Wojciech Krzyzanski
Time-dependent clearance and hematological pharmacodynamics upon erythropoietin multiple dosing in rats.
Biopharmaceutics & drug disposition 2010;31(5-6):298-315.
2010: Déborah Hirt; Julien Fonsart; Marie-Claude Menet; Marcel Debray; Florence Noble; Xavier Declèves; Jean-Michel Scherrmann
Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.
Toxicological sciences : an official journal of the Society of Toxicology 2010;114(1):38-47.
2010: Carole Giraud; Sandra Manceau; Xavier Declèves; François Goffinet; Jean-Pierre Morini; Hélène Chappuy; Frédéric Batteux; Sandrine Chouzenoux; Salah Yousif; Jean-Michel Scherrmann; Stéphane Blanche; Jean-Marc Tréluyer
Influence of development, HIV infection, and antiretroviral therapies on the gene expression profiles of ABC transporters in human lymphocytes.
Journal of clinical pharmacology 2010;50(2):226-30.
2009: Julien Fonsart; Marie-Claude Menet; Marcel Debray; Déborah Hirt; Florence Noble; Jean-Michel Scherrmann; Xavier Declèves
Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
Toxicology and applied pharmacology 2009;241(3):339-47.
2009: Nicolas Tournier; Pascal André; Sandy Blondeel; Nathalie Rizzo-Padoin; Amaury du Moulinet d'Hardemarre; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino
Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.
Journal of pharmaceutical sciences 2009;98(12):4650-60.
2009: Jean-Michel Scherrmann
Transporters in absorption, distribution, and elimination.
Chemistry & biodiversity 2009;6(11):1933-42.
2009: Agnès Poirier; Christoph Funk; Jean-Michel Scherrmann; Thierry Lavé
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Molecular pharmaceutics 2009;6(6):1716-33.
2009: Emilie Belkaï; Jean-Michel Scherrmann; Florence Noble; Cynthia Marie-Claire
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
Addiction biology 2009;14(3):245-52.
2009: Pascal André; Marcel Debray; Jean-Michel Scherrmann; salvatore cisternino
Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(7):1293-304.
2009: Sandrine Dauchy; Florence Miller; Pierre-Olivier Couraud; Richard J Weaver; Babette Weksler; Ignacio Romero; Jean-Michel Scherrmann; Isabelle de Waziers; Xavier Declèves
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.
Biochemical pharmacology 2009;77(5):897-909.
2009: Julie Cattelotte; Nicolas Tournier; Nathalie Rizzo-Padoin; Alfred H Schinkel; Jean-Michel Scherrmann; salvatore cisternino
Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Journal of neurochemistry 2009;108(3):767-75.
2009: Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean-Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Pharmacology of morphine in obese patients: clinical implications.
Clinical pharmacokinetics 2009;48(10):635-51.
2008: Craig K Svensson; Jean-Michel Scherrmann
Commentary: current advances and future directions for CNS delivery.
The AAPS journal 2008;10(4):587-8.
2008: Stephane Desjardins; Emilie Belkai; Dominique Crete; Laurie Cordonnier; Jean-Michel Scherrmann; Florence Noble; Cynthia Marie-Claire
Effects of chronic morphine and morphine withdrawal on gene expression in rat peripheral blood mononuclear cells.
Neuropharmacology 2008;55(8):1347-54.
2008: salah yousif; Bruno Saubaméa; salvatore cisternino; Cynthia Marie-Claire; Sandrine Dauchy; Jean-Michel Scherrmann; Xavier Declèves
Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein.
Journal of neurochemistry 2008;107(3):647-57.
2008: Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
CNS delivery via adsorptive transcytosis.
The AAPS journal 2008;10(3):455-72.
2008: Françoise Hervé; Nicolae Ghinea; Philippe d'Athis; Pierre-Alain Carrupt; Jean-Michel Scherrmann
Covalent modifications of antitetanus F(ab')2 fragments with natural and synthetic polyamines and their effects on the antibody endocytosis in cultured HL60 cells.
Bioconjugate chemistry 2008;19(8):1543-55.
2008: Julie Cattelotte; Pascal André; Mélissa Ouellet; Fanchon Bourasset; Jean-Michel Scherrmann; salvatore cisternino
In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(8):1449-59.
2008: Julien Fonsart; Marie-Claude Menet; Xavier Declèves; Hervé Galons; Dominique Crété; Marcel Debray; Jean-Michel Scherrmann; Florence Noble
Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Toxicology and applied pharmacology 2008;230(1):117-25.
2008: Xavier Declèves; Sébastien Bihorel; Marcel Debray; salah yousif; Gian Camenisch; Jean-Michel Scherrmann
ABC transporters and the accumulation of imatinib and its active metabolite CGP74588 in rat C6 glioma cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;57(3):214-22.
2007: Sébastien Bihorel; Gian Camenisch; Michel Lemaire; Jean-Michel Scherrmann
Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Journal of neurochemistry 2007;102(6):1749-57.
2007: Sébastien Bihorel; Gian Camenisch; Michel Lemaire; Jean-Michel Scherrmann
Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar.
Pharmaceutical research 2007;24(9):1720-8.
2007: Nicolas Perrière; salah yousif; Sylvie Cazaubon; Nathalie Chaverot; Fanchon Bourasset; salvatore cisternino; Xavier Declèves; Satoko Hori; Tetsuya Terasaki; Mária A Deli; Jean-Michel Scherrmann; Jamal Temsamani; Françoise Roux; Pierre-Olivier Couraud
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Brain research 2007;1150():1-13.
2007: salah yousif; Cynthia Marie-Claire; Françoise Roux; Jean-Michel Scherrmann; Xavier Declèves
Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy.
Brain research 2007;1134(1):1-11.
2006: Elisabeth Niel; Jean-Michel Scherrmann
Colchicine today.
Joint, bone, spine : revue du rhumatisme 2006;73(6):672-8.
2006: Xavier Declèves; Elisabeth Niel; Marcel Debray; Jean-Michel Scherrmann
Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?
Toxicology and applied pharmacology 2006;217(2):153-60.
2006: Sébastien Bihorel; Gian Camenisch; Gerhard Gross; Michel Lemaire; Jean-Michel Scherrmann
Influence of hydroxyurea on imatinib mesylate (gleevec) transport at the mouse blood-brain barrier.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(12):1945-9.
2006: Xavier Declèves; Alexandra Amiel; Jean-Yves Delattre; Jean-Michel Scherrmann
Role of ABC transporters in the chemoresistance of human gliomas.
Current cancer drug targets 2006;6(5):433-45.
2006: Fanchon Bourasset; Jean-Michel Scherrmann
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide.
Life sciences 2006;78(20):2302-14.
2006: Caroline Gadjou; Dominique Blanchard; Yannic Danger; Gilles Folléa; Pierre Sandouk; Jean-Michel Scherrmann; Hervé Galons
Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.
International journal of biomedical science : IJBS 2006;2(1):53-8.
2005: Frédéric Welfringer; Philippe d'Athis; Jean-Michel Scherrmann; Françoise Hervé
Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Journal of immunological methods 2005;307(1-2):82-95.
2005: Jean-Michel Scherrmann
Expression and function of multidrug resistance transporters at the blood-brain barriers.
Expert opinion on drug metabolism & toxicology 2005;1(2):233-46.
2005: Fanchon Bourasset; Katy Bernard; Carmen Muñoz; Patrick Genissel; Jean-Michel Scherrmann
Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(8):1137-43.
2005: Jamal Temsamani; Cécile Bonnafous; Christophe Rousselle; Yannik Fraisse; Philippe Clair; Luc-André Granier; Anthony R Rees; Michel Kaczorek; Jean-Michel Scherrmann
Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy.
The Journal of pharmacology and experimental therapeutics 2005;313(2):712-9.
2005: Nicolas Perrière; Ph Demeuse; E Garcia; A Regina; M Debray; Jean P Andreux; P Couvreur; Jean-Michel Scherrmann; Jamal Temsamani; Pierre-Olivier Couraud; Mária A Deli; Françoise Roux
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties.
Journal of neurochemistry 2005;93(2):279-89.
2004: Nawal Serradji; Marc Martin; Okkacha Bensaid; salvatore cisternino; Christophe Rousselle; Nathalie Dereuddre-Bosquet; Jack Huet; Catherine Redeuilh; Aazdine Lamouri; Chang-Zhi Dong; Pascal Clayette; Jean-Michel Scherrmann; Dominique Dormont; Françoise Heymans
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity.
Journal of medicinal chemistry 2004;47(25):6410-9.
2004: Emmanuelle Blanc; Cécile Bonnafous; Peggy Merida; salvatore cisternino; Philippe Clair; Jean-Michel Scherrmann; Jamal Temsamani
Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel.
Anti-cancer drugs 2004;15(10):947-54.
2004: Claire Mercier; Christophe Masseguin; Françoise Roux; Jacqueline Gabrion; Jean-Michel Scherrmann
Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes.
Brain research 2004;1021(1):32-40.
2004: salvatore cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
Pharmaceutical research 2004;21(8):1382-9.
2004: salvatore cisternino; Claire Mercier; Fanchon Bourasset; Françoise Roux; Jean-Michel Scherrmann
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cancer research 2004;64(9):3296-301.
2004: Merav Lidar; Jean-Michel Scherrmann; Yael Shinar; Angela Chetrit; Elisabeth Niel; Ruth Gershoni-Baruch; Pnina Langevitz; Avi Livneh
Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization.
Seminars in arthritis and rheumatism 2004;33(4):273-82.
2004: B Benyahia; S Huguet; Xavier Declèves; Karima Mokhtari; Emmanuelle Crinière; Jean-François Bernaudin; Jean-Michel Scherrmann; Jean-Yves Delattre
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Journal of neuro-oncology 2004;66(1-2):65-70.
2003: Claire Mercier; Xavier Declèves; Christophe Masseguin; PASCAL FRAGNER; Marcienne Tardy; Françoise Roux; Jacqueline Gabrion; Jean-Michel Scherrmann
P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes.
Journal of neurochemistry 2003;87(4):820-30.
2003: salvatore cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.
Pharmaceutical research 2003;20(10):1607-11.
2003: Fanchon Bourasset; salvatore cisternino; Jamal Temsamani; Jean-Michel Scherrmann
Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Journal of neurochemistry 2003;86(6):1564-7.
2003: Christophe Rousselle; Philippe Clair; Maria Smirnova; Yuri Kolesnikov; Gavril W Pasternak; Stephanie Gac-Breton; Anthony R Rees; Jean-Michel Scherrmann; Jamal Temsamani
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.
The Journal of pharmacology and experimental therapeutics 2003;306(1):371-6.
2003: salvatore cisternino; Christophe Rousselle; Aurelio Lorico; Germana Rappa; Jean-Michel Scherrmann
Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.
Pharmaceutical research 2003;20(6):904-9.
2003: salvatore cisternino; Fanchon Bourasset; Yves Archimbaud; Dorothée Sémiond; Gérard Sanderink; Jean-Michel Scherrmann
Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.
British journal of pharmacology 2003;138(7):1367-75.
2003: Igal Leibovitch; Yair Alster; Jean-Michel Scherrmann; Barak Azmon; Irina S Barequet; Avi Livneh; Terrence P O'Brien; Moshe Lazar; Anat Loewenstein
Colchicine in tear fluid of treated patients with familial Mediterranean fever.
Cornea 2003;22(3):191-3.
2003: Jamal Temsamani; Jean-Michel Scherrmann
Peptide vectors as drug carriers.
Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques 2003;61():221-38.
2003: V Lemercier; X Millot; E Ansoborlo; F Ménétrier; A Flüry-Hérard; Christophe Rousselle; Jean-Michel Scherrmann
Study of uranium transfer across the blood-brain barrier.
Radiation protection dosimetry 2003;105(1-4):243-5.
2002: Christophe Rousselle; Philippe Clair; Jamal Temsamani; Jean-Michel Scherrmann
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy.
Journal of drug targeting 2002;10(4):309-15.
2002: Xavier Declèves; Anne Fajac; Jacqueline Lehmann-Che; Marcienne Tardy; Claire Mercier; Ilse Hurbain; Jean-Louis Laplanche; Jean-François Bernaudin; Jean-Michel Scherrmann
Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
International journal of cancer. Journal international du cancer 2002;98(2):173-80.
2002: Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.
AAPS pharmSci 2002;4(4):E26.
2001: Jamal Temsamani; Christophe Rousselle; Anthony R Rees; Jean-Michel Scherrmann
Vector-mediated drug delivery to the brain.
Expert opinion on biological therapy 2001;1(5):773-82.
2001: salvatore cisternino; Christophe Rousselle; Claude Dagenais; Jean-Michel Scherrmann
Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.
Pharmaceutical research 2001;18(2):183-90.
2001: Martine Mazel; Philippe Clair; Christophe Rousselle; Pierre Vidal; Jean-Michel Scherrmann; D Mathieu; Jamal Temsamani
Doxorubicin-peptide conjugates overcome multidrug resistance.
Anti-cancer drugs 2001;12(2):107-16.
2001: F Hervé; J Ouzilou-Girod; Jean-Michel Scherrmann
[Cationization, a process for the delivery of antibodies to the central nervous system. Problems encountered in its application for immunotherapy strategies such as those for clostridial poisoning].
Journal de la Société de biologie 2001;195(3):201-27.
2001: Christophe Rousselle; M Smirnova; Philippe Clair; J M Lefauconnier; Alain Chavanieu; Bernard Calas; Jean-Michel Scherrmann; Jamal Temsamani
Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.
The Journal of pharmacology and experimental therapeutics 2001;296(1):124-31.
2000: Xavier Declèves; A Regina; Jean-Louis Laplanche; Françoise Roux; Bernadette Boval; J M Launay; Jean-Michel Scherrmann
Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.
Journal of neuroscience research 2000;60(5):594-601.
2000: Christophe Rousselle; Philippe Clair; J M Lefauconnier; Michel Kaczorek; Jean-Michel Scherrmann; Jamal Temsamani
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.
Molecular pharmacology 2000;57(4):679-86.
2000: Claude Dagenais; Christophe Rousselle; Gary M Pollack; Jean-Michel Scherrmann
Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(2):381-6.
2000: G Hong; O Chappey; Elisabeth Niel; Jean-Michel Scherrmann
Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization.
Journal of drug targeting 2000;8(2):67-77.
1999: J Girod; Laurence Fenart; Anthony Régina; Marie-Pierre Dehouck; G Hong; Jean-Michel Scherrmann; Roméo Cecchelli; Françoise Roux
Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway.
Journal of neurochemistry 1999;73(5):2002-8.
1999: F Stain-Texier; Gabrielle Boschi; P Sandouk; Jean-Michel Scherrmann
Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.
British journal of pharmacology 1999;128(4):917-24.
1999: E Weinling; P Sandouk; Marcel Debray; Jean-Michel Scherrmann
Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
International journal of clinical pharmacology and therapeutics 1999;37(10):503-9.
1999: C Renard; E Weinling; B Pau; Jean-Michel Scherrmann
Time- and dose-dependent digoxin redistribution by digoxin-specific antigen binding fragments in a rat model.
Toxicology 1999;137(2):117-27.
1999: Chuong Pham-Huy; F Stathoulopoulou; P Sandouk; Jean-Michel Scherrmann; S Palombo; C Girre
Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution.
Journal of chromatography. B, Biomedical sciences and applications 1999;732(1):47-53.
1999: C Renard; O Chappey; Marie-Paule Wautier; M Nagashima; J Morser; Jean-Michel Scherrmann; Jean-Luc Wautier
The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats.
The Journal of pharmacology and experimental therapeutics 1999;290(3):1458-66.
1999: JP Coudereau; F Stain; N Drion; P Sandouk; Claire Monier; Marcel Debray; Jean-Michel Scherrmann; Jean-Marie Bourre; Henriette Francès
Effect of social isolation on the metabolism of morphine and its passage through the blood-brain barrier and on consumption of sucrose solutions.
Psychopharmacology 1999;144(3):198-204.
1999: G Hong; MI Bazin-Redureau; Jean-Michel Scherrmann
Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.
Journal of pharmaceutical sciences 1999;88(1):147-53.
1998: C Ragusi; Gabrielle Boschi; Patricia Risède; R Rips; K Harrison; Jean-Michel Scherrmann
Influence of various combinations of specific antibody dose and affinity on tissue imipramine redistribution.
British journal of pharmacology 1998;125(1):35-40.
1998: G Hong; MI Bazin-Redureau; P Gires; Jean-Michel Scherrmann
Hepatic disposition and toxicity of cationized goat immunoglobulin G and fab fragments in isolated perfused rat liver.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(7):661-9.
1998: MI Bazin-Redureau; S Pepin; G Hong; M Debray; Jean-Michel Scherrmann
Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.
Toxicology and applied pharmacology 1998;150(2):295-300.
1998: Xavier Declèves; O Chappey; Bernadette Boval; Elisabeth Niel; Jean-Michel Scherrmann
P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
Pharmaceutical research 1998;15(5):712-8.
1998: C Ragusi; Jean-Michel Scherrmann; K Harrison; D S Smith; R Rips; Gabrielle Boschi
Redistribution of imipramine from regions of the brain under the influence of circulating specific antibodies.
Journal of neurochemistry 1998;70(5):2099-105.
1998: F Stain-Texier; P Sandouk; Jean-Michel Scherrmann
Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(5):383-7.
1998: E Advenier; S Mouajjah; MI Bazin-Redureau; J M Launay; Jean-Michel Scherrmann
Renal tolerance of digoxin-specific Fab fragments in the rat.
Toxicology 1998;126(3):223-9.
1998: P A Evrard; C Ragusi; Gabrielle Boschi; R K Verbeeck; Jean-Michel Scherrmann
Simultaneous microdialysis in brain and blood of the mouse: extracellular and intracellular brain colchicine disposition.
Brain research 1998;786(1-2):122-7.
1998: S Pepin-Covatta; C Lutsch; J Lang; Jean-Michel Scherrmann
Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
Journal of pharmaceutical sciences 1998;87(2):221-5.
1997: C Renard; N Grene-Lerouge; N Beau; F Baud; Jean-Michel Scherrmann
Pharmacokinetics of digoxin-specific Fab: effects of decreased renal function and age.
British journal of clinical pharmacology 1997;44(2):135-8.
1997: C Renard; O Chappey; Marie-Paule Wautier; M Nagashima; E Lundh; J Morser; L Zhao; Ann Marie Schmidt; Jean-Michel Scherrmann; Jean-Luc Wautier
Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats.
Molecular pharmacology 1997;52(1):54-62.
1997: N Drion; P Risede; N Cholet; C Chanez; Jean-Michel Scherrmann
Role of P-170 glycoprotein in colchicine brain uptake.
Journal of neuroscience research 1997;49(1):80-8.
1997: B El Hafny; Noël Cano; M Piciotti; A Regina; Jean-Michel Scherrmann; Françoise Roux
Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line.
Biochemical pharmacology 1997;53(11):1735-42.
1997: MI Bazin-Redureau; C B Renard; Jean-Michel Scherrmann
Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat.
The Journal of pharmacy and pharmacology 1997;49(3):277-81.
1997: S Pépin-Covatta; C Lutsch; M Grandgeorge; Jean-Michel Scherrmann
Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxin.
Toxicon : official journal of the International Society on Toxinology 1997;35(3):411-22.
1996: S Pépin-Covatta; C Lutsch; M Grandgeorge; Jean Lang; Jean-Michel Scherrmann
Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Toxicology and applied pharmacology 1996;141(1):272-7.
1996: N Drion; M Lemaire; J M Lefauconnier; Jean-Michel Scherrmann
Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine.
Journal of neurochemistry 1996;67(4):1688-93.
1996: C Ragusi; Gabrielle Boschi; R Rips; Jean-Michel Scherrmann
Facilitation of imipramine efflux from the brain by systemic specific antibodies.
British journal of pharmacology 1996;118(8):2152-6.
1996: N A Grene-Lerouge; MI Bazin-Redureau; M Debray; Jean-Michel Scherrmann
Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.
Toxicology and applied pharmacology 1996;138(1):84-9.
1996: N J Cano; A E Sabouraud; Marcel Debray; Jean-Michel Scherrmann
Dose-dependent reversal of digoxin-inhibited activity of an in vitro Na+K+ATPase model by digoxin-specific antibody.
Toxicology letters 1996;85(2):107-11.
1996: S Desrayaud; Gabrielle Boschi; R Rips; Jean-Michel Scherrmann
Dose-dependent delivery of colchicine to the rat hippocampus by microdialysis.
Neuroscience letters 1996;205(1):9-12.
1996: Valérie Choumet; F Audebert; G Rivière; M Sorkine; M Urtizberea; A Sabouraud; Jean-Michel Scherrmann; Cassian Bon
New approaches in antivenom therapy.
Advances in experimental medicine and biology 1996;391():515-20.
1996: N Rizzo; C Padoin; S Palombo; Jean-Michel Scherrmann; C Girre
Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
European journal of clinical pharmacology 1996;49(6):491-5.
1996: Chantal Bismuth; Frédéric J Baud; Stephen Borron; Jean-Michel Scherrmann
Antibodies proposed as therapeutic agents.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1996;18():321-32.
1995: MI Bazin-Redureau; P Gires; P Chapelle; M Martinet; Jean-Michel Scherrmann
Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
Drug metabolism and disposition: the biological fate of chemicals 1995;23(12):1400-6.
1995: N J Cano; Isabelle Navarro-Teulon; Marcel Debray; Marc Piechaczyk; Jean-Michel Scherrmann
Affinity and dose-dependent digoxin Na+K+ATPase dissociation by monoclonal digoxin-specific antibodies.
Biochemical pharmacology 1995;50(11):1867-72.
1995: P Sandouk; O Chappey; M B d'Yvoire; Jean-Michel Scherrmann
Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.
Therapeutic drug monitoring 1995;17(5):544-8.
1995: S Pepin; C Lutsch; M Grandgeorge; Jean-Michel Scherrmann
Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
Pharmaceutical research 1995;12(10):1470-3.
1995: O Chappey; E Niel; Marcel Debray; Jean-Luc Wautier; Jean-Michel Scherrmann
Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.
The Journal of pharmacology and experimental therapeutics 1995;274(3):1072-6.
1995: F Stain; M J Barjavel; P Sandouk; M Plotkine; Jean-Michel Scherrmann; H N Bhargava
Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
The Journal of pharmacology and experimental therapeutics 1995;274(2):852-7.
1995: N J Cano; A E Sabouraud; K Benmoussa; F Roquet; Isabelle Navarro-Teulon; Jean-Claude Mani; Jean-Michel Scherrmann
Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.
Pharmaceutical research 1995;12(5):709-14.
1995: Frédéric J Baud; A Sabouraud; E Vicaut; P Taboulet; J Lang; Chantal Bismuth; J M Rouzioux; Jean-Michel Scherrmann
Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments.
The New England journal of medicine 1995;332(10):642-5.
1994: K Benmoussa; A Sabouraud; Jean-Michel Scherrmann; J M Bourre
Cyclosporin absorption is impaired by the fat substitutes, sucrose polyester and tricarballylate triester, in the rat.
Pharmaceutical research 1994;11(10):1458-61.
1994: A Sabouraud; O Chappey; T Dupin; Jean-Michel Scherrmann
Binding of colchicine and thiocolchicoside to human serum proteins and blood cells.
International journal of clinical pharmacology and therapeutics 1994;32(8):429-32.
1994: P Got; Frédéric J Baud; P Sandouk; O Diamant-Berger; Jean-Michel Scherrmann
Morphine disposition in opiate-intoxicated patients: relevance of nonspecific opiate immunoassays.
Journal of analytical toxicology 1994;18(4):189-94.
1994: O Chappey; E Niel; M Dervichian; Jean-Luc Wautier; Jean-Michel Scherrmann; D Cattan
Colchicine concentration in leukocytes of patients with familial Mediterranean fever.
British journal of clinical pharmacology 1994;38(1):87-9.
1994: O Chappey; Marcel Debray; E Niel; Jean-Michel Scherrmann
Association constants of monoclonal antibodies for hapten: heterogeneity of frequency distribution and possible relationship with hapten molecular weight.
Journal of immunological methods 1994;172(2):219-25.
1994: A Sabouraud; N Cano; Jean-Michel Scherrmann
Radioimmunoassay of colchicine with antisera exhibiting variable cross-reactivity.
Therapeutic drug monitoring 1994;16(2):179-85.
1994: F Audebert; M Urtizberea; A Sabouraud; Jean-Michel Scherrmann; Cassian Bon
Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1512-7.
1994: Jean-Michel Scherrmann
Antibody treatment of toxin poisoning--recent advances.
Journal of toxicology. Clinical toxicology 1994;32(4):363-75.
1994: M Rochdi; A Sabouraud; C Girre; R Venet; Jean-Michel Scherrmann
Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
European journal of clinical pharmacology 1994;46(4):351-4.
1994: M Barjavel; P Sandouk; M Plotkine; Jean-Michel Scherrmann
Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis.
Life sciences 1994;55(16):1301-8.
1993: A Sabouraud; M Redureau; P Gires; M Martinet; Jean-Michel Scherrmann
Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(6):997-1002.
1993: O Chappey; E Niel; Jean-Luc Wautier; P P Hung; M Dervichian; D Cattan; Jean-Michel Scherrmann
Colchicine disposition in human leukocytes after single and multiple oral administration.
Clinical pharmacology and therapeutics 1993;54(4):360-7.
1993: K Benmoussa; A Sabouraud; Jean-Michel Scherrmann; D Brossard; J M Bourre
Effect of fat substitutes, sucrose polyester and tricarballylate triester, on digitoxin absorption in the rat.
The Journal of pharmacy and pharmacology 1993;45(8):692-6.
1993: C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; Jean-Michel Scherrmann
Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.
Pharmaceutical research 1993;10(5):692-6.
1992: A E Sabouraud; M Urtizberea; K Benmoussa; N J Cano; Jean-Michel Scherrmann
Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
The Journal of pharmacy and pharmacology 1992;44(12):1015-9.
1992: O Chappey; P Sandouk; Jean-Michel Scherrmann
Monoclonal antibodies in hapten immunoassays.
Pharmaceutical research 1992;9(11):1375-9.
1992: M Rochdi; A Sabouraud; Frédéric J Baud; Chantal Bismuth; Jean-Michel Scherrmann
Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
Human & experimental toxicology 1992;11(6):510-6.
1992: N J Cano; A E Sabouraud; M Urtizberea; J Carcagne; M Grandgeorge; Jean-Michel Scherrmann
Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.
Pharmaceutical research 1992;9(5):643-7.
1992: A E Sabouraud; M Urtizberea; N J Cano; M Grandgeorge; J M Rouzioux; Jean-Michel Scherrmann
Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1214-9.
1992: A Sabouraud; M Rochdi; M Urtizberea; M O Christen; G Achtert; Jean-Michel Scherrmann
Pharmacokinetics of colchicine: a review of experimental and clinical data.
Zeitschrift für Gastroenterologie 1992;30 Suppl 1():35-9.
1992: M Urtizberea; A Sabouraud; F Baud; M Rochdi; Marcel Debray; Chantal Bismuth; Jean-Michel Scherrmann
Concepts for toxicokinetic-toxicodynamic modelling in clinical toxicology: application to acute cardiac glycoside intoxications.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1992;15():253-6.
1991: X Guédeney; C Chanez; A Grenier; Jean-Michel Scherrmann
Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
Clinical chemistry 1991;37(11):1900-4.
1991: M Urtizberea; A Sabouraud; N Cano; M Grandgeorge; J M Rouzioux; Jean-Michel Scherrmann
Reversal of murine colchicine toxicity by colchicine-specific Fab fragments.
Toxicology letters 1991;58(2):193-8.
1991: P Sandouk; Alain Serrie; M Urtizberea; Marcel Debray; P Got; Jean-Michel Scherrmann
Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.
Clinical pharmacology and therapeutics 1991;49(4):442-8.
1991: M Urtizberea; M Rochdi; A Sabouraud; Chantal Bismuth; Jean-Michel Scherrmann
Relationship between red blood cell potassium and plasma digitoxin concentrations in intoxicated patients.
Pharmacology & toxicology 1991;68(4):237-42.
1991: A Sabouraud; M Urtizberea; M Grandgeorge; P Gattel; M E Makula; Jean-Michel Scherrmann
Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragments.
Toxicology 1991;68(2):121-32.
1991: P Sandouk; Alain Serrie; Jean-Michel Scherrmann; A Langlade; Jean-Marie Bourre
Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine.
European journal of drug metabolism and pharmacokinetics 1991;Spec No 3():166-71.
1991: M Urtizberea; A Sabouraud; M Lachaise; O Chappey; V Cosson; Frédéric J Baud; Jean-Michel Scherrmann
Pharmacokinetics of total and free digoxin and Fab fragments in 5 intoxicated patients after administration of specific anti-digoxin Fab fragments.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1991;14():132-5.
1990: P Houzé; O Chappey; H Gallons; Jean-Michel Scherrmann
1-Methyl-4-phenylpyridinium (MPP+) does not exhibit paraquat-like immunoreactivity.
Toxicology letters 1990;53(3):339-42.
1990: N Terrien; M Urtizberea; Jean-Michel Scherrmann
Reversal of advanced colchicine toxicity in mice with goat colchicine-specific antibodies.
Toxicology and applied pharmacology 1990;104(3):504-10.
1990: A Sabouraud; H Denis; M Urtizberea; O Chappey; Jean-Michel Scherrmann
The effect of nortriptyline-specific active immunization on amitriptyline toxicity and disposition in the rabbit.
Toxicology 1990;62(3):349-60.
1990: A Sabouraud; M Urtizberea; N Cano; R Garnier; Jean-Michel Scherrmann
Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning?
Human & experimental toxicology 1990;9(3):191-3.
1990: M Urtizberea; M Latour; L Edelman; J Carcagne; J Armand; Jean-Michel Scherrmann
Immunopharmacological activity of monoclonal antidigitoxin.
Developments in biological standardization 1990;71():147-57.
1989: N Terrien; M Urtizberea; Jean-Michel Scherrmann
Influence of goat colchicine specific antibodies on murine colchicine disposition.
Toxicology 1989;59(1):11-22.
1989: G Achtert; Jean-Michel Scherrmann; M O Christen
Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.
European journal of drug metabolism and pharmacokinetics 1989;14(4):317-22.
1989: Jean-Michel Scherrmann; M Urtizberea; P Pierson; N Terrien
The effect of colchicine-specific active immunization on colchicine toxicity and disposition in the rabbit.
Toxicology 1989;56(2):213-22.
1989: Jean-Michel Scherrmann; N Terrien; M Urtizberea; P Pierson; H Denis; Jean-Marie Bourre
Immunotoxicotherapy: present status and future trends.
Journal of toxicology. Clinical toxicology 1989;27(1-2):1-35.
1989: M Urtizberea; Jean-Marie Bourre; Marcel Debray; Jean-Michel Scherrmann
Comparison of colchicine toxicity on different dysmyelinating mutant models.
Neurotoxicology 1989;10(2):211-7.
1986: Jean-Michel Scherrmann; P Sandouk; X Guedeney
Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
Clinical biochemistry 1986;19(4):201-4.
1986: P Sandouk; Jean-Michel Scherrmann; M Galliot; R Bourdon
[Guidelines for prescription of the assay of digitalis glycosides by immunologic methods].
Presse médicale (Paris, France : 1983) 1986;15(27):1273-5.
1986: Jean-Michel Scherrmann; P Sandouk; X Guedeney
Digitalis-like factors and digoxin pharmacokinetics.
Chest 1986;89(3):468-9.
1986: P Sandouk; Jean-Michel Scherrmann; J Barrier; N Ciraru-Vigneron; X Guedeney; R Bourdon
[Endogenous digitalis-like substances in umbilical cord blood: analytical interference or new hormones?].
Journal de gynécologie, obstétrique et biologie de la reproduction 1986;15(6):737-42.
1986: Jean-Michel Scherrmann; P Sandouk; X Guedeney
Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
Clinical chemistry 1986;32(1 Pt 1):97-100.
1986: Jean-Michel Scherrmann; N Terrien; M Urtizberea; P Pierson; Jean-Marie Bourre
[Immunotoxicotherapy: protective effect of anti-colchicine antibodies in acute colchicine poisoning in rabbits and mice].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;302(19):661-4.
1985: Jean-Michel Scherrmann; P Sandouk; X Guedeney
[Digoxin assay in neonatology].
Presse médicale (Paris, France : 1983) 1985;14(36):1889.
1984: P Sandouk; Jean-Michel Scherrmann; R Bourdon
Combined liquid-solid chromatography and radioimmunoassay for determination of morphine in human fluids.
Journal of pharmacological methods 1984;11(4):227-37.